Delivery Order SPE2DB22D2211-SPE2DB24FPGF6

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of PROPARACAINE 0.5% EYE DROPS 15ML. The contract has a ceiling value of $1,070.12 and is a firm fixed-price contract. The funding agency is the Defense Logistics Agency (DLA), a defense agency. The contract is not set-aside and is therefore open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,007.16 firm fixed-price delivery order is for the supply of PROPARACAINE 0.5% EYE DROPS 15ML. The contract has an ultimate completion date of April 3, 2025 and was awarded on April 2, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $8,188.38 to AmerisourceBergen Drug Corp for the supply of 4565391207 PROPARACAINE 0.5% EYE DROPS 15ML. This contract has an ultimate completion date of August 9, 2024 and is a Firm Fixed Price contract. AmerisourceBergen, a major pharmaceutical distributor, will provide these critical medical supplies to support military treatment facilities and other federal healthcare providers. The contract is not associated with a...
This federal contract award, valued at $1,802.24, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of PROPARACAINE 0.5% EYE DROPS 15ML, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of November 19, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,789.92 fixed-price delivery order is for the procurement of 4566776053 - PROPARACAINE 0.5% EYE DROPS 15ML, with a completion date of December 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,097.76, is a Delivery Order for the supply of PROPARACAINE 0.5% EYE DROPS 15ML. The contract has an ultimate completion date of January 15, 2025 and is a Firm Fixed Price contract. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of Proparacaine 0.5% eye drops, 15ml, to the Defense Logistics Agency (DLA), a defense agency. The $2,506.20 firm fixed-price delivery order has a completion date of June 18, 2025 and was awarded on June 17, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of proparacaine 0.5% eye drops. The award, valued at $1,158.71, is a Firm Fixed Price Delivery Order that is not set aside for any specific business size or socioeconomic category. The contract has a completion date of August 30, 2024. Amerisourcebergen, through its Corporate Office Division, has been awarded...
This federal contract award, valued at $1,423.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of Proparacaine 0.5% eye drops, a prescription medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,061.28 Firm Fixed Price Delivery Order is for the provision of PROPARACAINE 0.5% EYE DROPS 15ML, a common medical product used in federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FPGF6
    Delivery Order

This federal contract award is for the supply of PROPARACAINE 0.5% EYE DROPS 15ML by Amerisourcebergen Drug Corp to the Defense Logistics Agency (DLA). The contract, valued at $2,237.40, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The current delivery order has a firm fixed-price and a completion date of August 30, 2024. This contract award does not have a set-aside designation.

Generated 11/28/24, 9:21 AM